These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1015 related items for PubMed ID: 15604233
1. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy. Stagg J, Wu JH, Bouganim N, Galipeau J. Cancer Res; 2004 Dec 15; 64(24):8795-9. PubMed ID: 15604233 [Abstract] [Full Text] [Related]
2. The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation. Penafuerte C, Bautista-Lopez N, Boulassel MR, Routy JP, Galipeau J. Cancer Res; 2009 Dec 01; 69(23):9020-8. PubMed ID: 19920194 [Abstract] [Full Text] [Related]
3. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A. Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814 [Abstract] [Full Text] [Related]
4. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Wakimoto H, Abe J, Tsunoda R, Aoyagi M, Hirakawa K, Hamada H. Cancer Res; 1996 Apr 15; 56(8):1828-33. PubMed ID: 8620500 [Abstract] [Full Text] [Related]
5. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma]. Guo C, Liu QG, Yang W, Yao YM. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb 15; 28(2):188-92. PubMed ID: 18250039 [Abstract] [Full Text] [Related]
6. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes. Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC. Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137 [Abstract] [Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF. Shi FS, Weber S, Gan J, Rakhmilevich AL, Mahvi DM. Cancer Gene Ther; 1999 Mar 15; 6(1):81-8. PubMed ID: 10078967 [Abstract] [Full Text] [Related]
9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H. Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645 [Abstract] [Full Text] [Related]
17. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model. Zhao F, Dou J, He XF, Wang J, Chu L, Hu W, Yu F, Hu K, Wu Y, Gu N. Vaccine; 2010 Apr 01; 28(16):2846-52. PubMed ID: 20153795 [Abstract] [Full Text] [Related]
18. Antigens and cytokine genes in antitumor vaccines: the importance of the temporal delivery sequence in antitumor signals. Herrero MJ, Botella R, Dasí F, Algás R, Sánchez M, Aliño SF. Ann N Y Acad Sci; 2006 Dec 01; 1091():412-24. PubMed ID: 17341632 [Abstract] [Full Text] [Related]